These and other tools included in the “COVereD” platform aim to help healthcare providers more effectively triage and monitor their patients and workforces amid the rapid spread of the virus with the help of digital tools and services.
The toolkit was built in partnership with several of Rx.Health’s technology partners: Microsoft for cloud support, Curai for AI-powered patient screening, Suki AI’s clinical digital assistant and Redox for ecosystem integration.
“Digital health solutions can help in prevention, triage and monitoring of COVID-19. We need a holistic approach that integrates a vast array of tools to intelligently deliver proactive outreach campaigns, digital triage through bots, referral to telehealth care and close surveillance for those in voluntary quarantine,” Ashish Atreja, MD, chief innovation officer of Mount Sinai and scientific founder of Rx.Health, said in a March 16 news release.
Gaurav Narang, PhD, Rx.Health’s vice president of strategic partnerships, added, “Based on evidence-based disease pathways, COVereD is built to support customization at multiple levels. Our digital toolkit can be implemented within a day with minimal training necessary, and to make it accessible widely across facilities of all sizes, we are temporarily waiving platform license fees for the duration of COVID-19 outbreak.”
Learn more about COVereD here.
More articles on innovation:
How Verily chose provider partners Atrius Health & Wake Forest Baptist — and vice versa — and how they’re protecting patient data
Hackensack Meridian innovation center launches diagnostic tool to speed COVID-19 tests
Israel medical center joins Chicago health innovation center project
